| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hispanic Americans | 48 | 2020 | 930 | 2.750 |
Why?
|
| Agriculture | 34 | 2020 | 194 | 2.410 |
Why?
|
| Occupational Exposure | 26 | 2020 | 231 | 2.100 |
Why?
|
| Pesticides | 22 | 2020 | 196 | 2.080 |
Why?
|
| Transients and Migrants | 31 | 2019 | 298 | 1.800 |
Why?
|
| Occupational Diseases | 15 | 2016 | 78 | 1.380 |
Why?
|
| North Carolina | 73 | 2020 | 1546 | 1.350 |
Why?
|
| Emigrants and Immigrants | 17 | 2018 | 240 | 1.030 |
Why?
|
| Occupational Health | 15 | 2019 | 84 | 0.940 |
Why?
|
| Agricultural Workers' Diseases | 9 | 2015 | 84 | 0.820 |
Why?
|
| Housing | 10 | 2016 | 65 | 0.820 |
Why?
|
| Male | 94 | 2020 | 19641 | 0.760 |
Why?
|
| Food-Processing Industry | 9 | 2015 | 37 | 0.750 |
Why?
|
| Humans | 109 | 2020 | 32798 | 0.730 |
Why?
|
| Adult | 64 | 2019 | 9560 | 0.690 |
Why?
|
| Female | 86 | 2020 | 20261 | 0.660 |
Why?
|
| Middle Aged | 62 | 2020 | 12125 | 0.650 |
Why?
|
| Aged | 43 | 2020 | 10538 | 0.590 |
Why?
|
| Atherosclerosis | 11 | 2016 | 788 | 0.590 |
Why?
|
| Cardiovascular Diseases | 7 | 2019 | 1140 | 0.570 |
Why?
|
| Prevalence | 17 | 2019 | 1002 | 0.540 |
Why?
|
| Data Interpretation, Statistical | 3 | 2007 | 114 | 0.540 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2015 | 121 | 0.540 |
Why?
|
| Life Style | 2 | 2017 | 407 | 0.540 |
Why?
|
| Musculoskeletal Diseases | 6 | 2014 | 42 | 0.520 |
Why?
|
| Depression | 8 | 2016 | 448 | 0.500 |
Why?
|
| Mobility Limitation | 1 | 2018 | 220 | 0.490 |
Why?
|
| Sampling Studies | 2 | 2006 | 44 | 0.480 |
Why?
|
| Carpal Tunnel Syndrome | 5 | 2014 | 61 | 0.480 |
Why?
|
| Cross-Sectional Studies | 25 | 2020 | 1572 | 0.470 |
Why?
|
| Macaca fascicularis | 13 | 2013 | 431 | 0.460 |
Why?
|
| Poultry | 6 | 2015 | 25 | 0.450 |
Why?
|
| Environmental Pollutants | 3 | 2010 | 21 | 0.430 |
Why?
|
| Oral Health | 6 | 2011 | 29 | 0.420 |
Why?
|
| Soybean Proteins | 6 | 2010 | 77 | 0.420 |
Why?
|
| Rural Population | 10 | 2016 | 286 | 0.400 |
Why?
|
| Antihypertensive Agents | 2 | 2015 | 352 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2015 | 1462 | 0.400 |
Why?
|
| Pyrethrins | 3 | 2018 | 12 | 0.370 |
Why?
|
| Young Adult | 26 | 2016 | 2730 | 0.360 |
Why?
|
| Longitudinal Studies | 10 | 2018 | 779 | 0.360 |
Why?
|
| Stress, Psychological | 5 | 2015 | 226 | 0.350 |
Why?
|
| Blood Pressure | 1 | 2015 | 862 | 0.350 |
Why?
|
| Risk Factors | 20 | 2016 | 3974 | 0.340 |
Why?
|
| Limit of Detection | 1 | 2010 | 15 | 0.340 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2010 | 4 | 0.340 |
Why?
|
| Insecticides | 3 | 2018 | 21 | 0.340 |
Why?
|
| Organophosphorus Compounds | 5 | 2018 | 32 | 0.320 |
Why?
|
| Logistic Models | 8 | 2012 | 783 | 0.320 |
Why?
|
| Adolescent | 22 | 2019 | 3638 | 0.310 |
Why?
|
| Diet | 6 | 2012 | 390 | 0.300 |
Why?
|
| Primary Health Care | 5 | 2009 | 231 | 0.290 |
Why?
|
| Isoflavones | 4 | 2010 | 79 | 0.290 |
Why?
|
| Poultry Products | 3 | 2012 | 13 | 0.280 |
Why?
|
| Fungicides, Industrial | 2 | 2018 | 9 | 0.270 |
Why?
|
| Biometry | 1 | 2007 | 13 | 0.270 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 24 | 0.270 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 126 | 0.260 |
Why?
|
| Environmental Exposure | 3 | 2020 | 89 | 0.260 |
Why?
|
| Carbamates | 2 | 2018 | 15 | 0.250 |
Why?
|
| Tennis Elbow | 4 | 2014 | 18 | 0.250 |
Why?
|
| Coronary Artery Disease | 4 | 2015 | 413 | 0.250 |
Why?
|
| Seasons | 7 | 2016 | 89 | 0.250 |
Why?
|
| Ethnic Groups | 7 | 2016 | 474 | 0.240 |
Why?
|
| Interviews as Topic | 11 | 2014 | 272 | 0.240 |
Why?
|
| Demography | 1 | 2006 | 110 | 0.240 |
Why?
|
| Ovarian Follicle | 3 | 2010 | 29 | 0.240 |
Why?
|
| Back Pain | 3 | 2014 | 29 | 0.240 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 422 | 0.230 |
Why?
|
| Neoplasms | 2 | 2015 | 761 | 0.230 |
Why?
|
| Cholinesterases | 3 | 2016 | 10 | 0.230 |
Why?
|
| United States | 13 | 2020 | 4108 | 0.220 |
Why?
|
| Heat Stress Disorders | 2 | 2015 | 11 | 0.220 |
Why?
|
| Nicotine | 2 | 2017 | 177 | 0.220 |
Why?
|
| Mass Screening | 4 | 2013 | 268 | 0.220 |
Why?
|
| Anti-Mullerian Hormone | 4 | 2012 | 15 | 0.220 |
Why?
|
| Complementary Therapies | 3 | 2019 | 80 | 0.210 |
Why?
|
| Cholesterol | 5 | 2009 | 253 | 0.210 |
Why?
|
| Nutrition Surveys | 4 | 2017 | 150 | 0.210 |
Why?
|
| Animals | 22 | 2015 | 7569 | 0.200 |
Why?
|
| Follow-Up Studies | 8 | 2015 | 2284 | 0.200 |
Why?
|
| Socioeconomic Factors | 9 | 2016 | 436 | 0.200 |
Why?
|
| Brain | 3 | 2017 | 946 | 0.200 |
Why?
|
| Vitamin K 1 | 2 | 2013 | 11 | 0.190 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 4032 | 0.190 |
Why?
|
| Mexican Americans | 3 | 2018 | 60 | 0.190 |
Why?
|
| Estradiol | 5 | 2012 | 121 | 0.190 |
Why?
|
| Obesity | 3 | 2019 | 1152 | 0.190 |
Why?
|
| Premenopause | 3 | 2012 | 44 | 0.190 |
Why?
|
| Estrogen Replacement Therapy | 3 | 2008 | 195 | 0.190 |
Why?
|
| Safety Management | 2 | 2012 | 38 | 0.180 |
Why?
|
| Hypertension | 4 | 2015 | 976 | 0.180 |
Why?
|
| Cotinine | 3 | 2017 | 52 | 0.180 |
Why?
|
| Respiratory Tract Diseases | 2 | 2012 | 35 | 0.170 |
Why?
|
| Coronary Vessels | 3 | 2013 | 164 | 0.170 |
Why?
|
| Health Status | 5 | 2020 | 402 | 0.170 |
Why?
|
| Skin Diseases | 2 | 2013 | 145 | 0.170 |
Why?
|
| Workplace | 4 | 2014 | 50 | 0.170 |
Why?
|
| Postmenopause | 4 | 2013 | 427 | 0.170 |
Why?
|
| Alcoholism | 3 | 2016 | 102 | 0.170 |
Why?
|
| Hygiene | 2 | 2012 | 13 | 0.170 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 576 | 0.160 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2013 | 138 | 0.160 |
Why?
|
| Health Behavior | 3 | 2016 | 234 | 0.160 |
Why?
|
| Hierarchy, Social | 2 | 2010 | 25 | 0.160 |
Why?
|
| Electrocardiography | 3 | 2020 | 636 | 0.160 |
Why?
|
| Autonomic Nervous System | 1 | 2020 | 44 | 0.160 |
Why?
|
| Guideline Adherence | 3 | 2009 | 120 | 0.160 |
Why?
|
| Dental Care for Aged | 2 | 2009 | 6 | 0.150 |
Why?
|
| Medroxyprogesterone Acetate | 3 | 2008 | 100 | 0.150 |
Why?
|
| Oral Hygiene | 2 | 2009 | 16 | 0.150 |
Why?
|
| Smell | 2 | 2017 | 48 | 0.150 |
Why?
|
| Tobacco | 2 | 2018 | 58 | 0.150 |
Why?
|
| Child | 7 | 2020 | 2478 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2015 | 469 | 0.150 |
Why?
|
| Mental Health | 2 | 2020 | 128 | 0.150 |
Why?
|
| Medicine, Traditional | 1 | 2019 | 22 | 0.150 |
Why?
|
| Dietary Supplements | 2 | 2013 | 187 | 0.150 |
Why?
|
| Heart | 1 | 2020 | 185 | 0.150 |
Why?
|
| Incidence | 7 | 2016 | 1238 | 0.150 |
Why?
|
| Butyrylcholinesterase | 3 | 2017 | 14 | 0.140 |
Why?
|
| Multivariate Analysis | 7 | 2015 | 682 | 0.140 |
Why?
|
| Aggression | 2 | 2016 | 30 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2015 | 908 | 0.140 |
Why?
|
| African Americans | 6 | 2015 | 1424 | 0.140 |
Why?
|
| Heart Rate | 1 | 2020 | 343 | 0.140 |
Why?
|
| Olfaction Disorders | 1 | 2017 | 7 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2018 | 195 | 0.140 |
Why?
|
| Hair Follicle | 1 | 2017 | 8 | 0.130 |
Why?
|
| Thiocarbamates | 1 | 2017 | 6 | 0.130 |
Why?
|
| Regression Analysis | 4 | 2017 | 288 | 0.130 |
Why?
|
| Hyperlipidemias | 2 | 2009 | 56 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2017 | 31 | 0.130 |
Why?
|
| Breast | 2 | 2008 | 64 | 0.130 |
Why?
|
| DNA Repair | 1 | 2017 | 57 | 0.130 |
Why?
|
| Food Supply | 1 | 2018 | 67 | 0.130 |
Why?
|
| Hypercholesterolemia | 2 | 2009 | 73 | 0.130 |
Why?
|
| Bayes Theorem | 1 | 2017 | 85 | 0.130 |
Why?
|
| DNA Damage | 1 | 2017 | 93 | 0.130 |
Why?
|
| Disability Evaluation | 1 | 2018 | 238 | 0.130 |
Why?
|
| Health Status Indicators | 2 | 2014 | 74 | 0.130 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 237 | 0.130 |
Why?
|
| Mexico | 5 | 2019 | 72 | 0.120 |
Why?
|
| Hot Temperature | 2 | 2013 | 78 | 0.120 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 28 | 0.120 |
Why?
|
| Bradycardia | 1 | 2016 | 18 | 0.120 |
Why?
|
| Shoulder Impingement Syndrome | 2 | 2012 | 11 | 0.120 |
Why?
|
| Cognition | 1 | 2020 | 551 | 0.120 |
Why?
|
| Postural Balance | 1 | 2018 | 180 | 0.120 |
Why?
|
| Acculturation | 1 | 2015 | 17 | 0.120 |
Why?
|
| Analysis of Variance | 3 | 2012 | 459 | 0.120 |
Why?
|
| Low Back Pain | 2 | 2014 | 47 | 0.120 |
Why?
|
| Lipids | 3 | 2013 | 229 | 0.120 |
Why?
|
| Prospective Studies | 6 | 2020 | 2327 | 0.120 |
Why?
|
| Iliac Artery | 3 | 2013 | 48 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 45 | 0.120 |
Why?
|
| Government Regulation | 2 | 2013 | 32 | 0.110 |
Why?
|
| DNA Methylation | 1 | 2016 | 144 | 0.110 |
Why?
|
| Mortality | 1 | 2016 | 124 | 0.110 |
Why?
|
| Environmental Monitoring | 3 | 2009 | 27 | 0.110 |
Why?
|
| Communication | 1 | 2016 | 141 | 0.110 |
Why?
|
| Airway Obstruction | 1 | 2015 | 32 | 0.110 |
Why?
|
| Food | 2 | 2018 | 42 | 0.110 |
Why?
|
| Learning | 1 | 2015 | 80 | 0.110 |
Why?
|
| Linear Models | 5 | 2015 | 445 | 0.110 |
Why?
|
| Safety | 2 | 2012 | 77 | 0.110 |
Why?
|
| Social Isolation | 1 | 2014 | 46 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 180 | 0.110 |
Why?
|
| Child Care | 1 | 2014 | 12 | 0.110 |
Why?
|
| Industry | 1 | 2014 | 15 | 0.110 |
Why?
|
| Occupations | 1 | 2014 | 10 | 0.110 |
Why?
|
| Dermatitis, Occupational | 1 | 2013 | 10 | 0.100 |
Why?
|
| Indians, North American | 5 | 2012 | 110 | 0.100 |
Why?
|
| Xerostomia | 2 | 2011 | 30 | 0.100 |
Why?
|
| Median Neuropathy | 1 | 2013 | 7 | 0.100 |
Why?
|
| Progesterone | 3 | 2010 | 69 | 0.100 |
Why?
|
| Fractures, Bone | 1 | 2015 | 161 | 0.100 |
Why?
|
| Quality of Life | 3 | 2014 | 961 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2013 | 69 | 0.100 |
Why?
|
| Meat-Packing Industry | 1 | 2013 | 7 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 256 | 0.100 |
Why?
|
| Lactalbumin | 2 | 2010 | 10 | 0.100 |
Why?
|
| Caseins | 2 | 2010 | 14 | 0.100 |
Why?
|
| Cognition Disorders | 2 | 2015 | 370 | 0.100 |
Why?
|
| Indoles | 1 | 2013 | 56 | 0.100 |
Why?
|
| Food Handling | 1 | 2012 | 7 | 0.100 |
Why?
|
| Feeding Behavior | 2 | 2012 | 158 | 0.100 |
Why?
|
| Eye Protective Devices | 1 | 2012 | 6 | 0.100 |
Why?
|
| Protective Clothing | 1 | 2012 | 25 | 0.090 |
Why?
|
| Physical Fitness | 1 | 2013 | 133 | 0.090 |
Why?
|
| Dental Health Services | 1 | 2012 | 11 | 0.090 |
Why?
|
| Personal Space | 1 | 2012 | 3 | 0.090 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2012 | 8 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2013 | 101 | 0.090 |
Why?
|
| Dental Anxiety | 1 | 2011 | 2 | 0.090 |
Why?
|
| Periodontal Diseases | 1 | 2011 | 18 | 0.090 |
Why?
|
| Dental Care | 1 | 2011 | 18 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2010 | 1012 | 0.090 |
Why?
|
| Cohort Studies | 5 | 2015 | 1844 | 0.090 |
Why?
|
| Contraceptive Agents, Female | 2 | 2008 | 15 | 0.090 |
Why?
|
| Homeless Persons | 1 | 2011 | 4 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 323 | 0.090 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2011 | 9 | 0.090 |
Why?
|
| Crime | 1 | 2011 | 7 | 0.090 |
Why?
|
| Dietary Proteins | 2 | 2010 | 55 | 0.090 |
Why?
|
| Family Characteristics | 1 | 2011 | 37 | 0.090 |
Why?
|
| Environmental Pollution | 1 | 2010 | 5 | 0.090 |
Why?
|
| Sexual Development | 1 | 2010 | 3 | 0.080 |
Why?
|
| Ovarian Diseases | 1 | 2010 | 7 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 476 | 0.080 |
Why?
|
| Continental Population Groups | 1 | 2012 | 236 | 0.080 |
Why?
|
| European Continental Ancestry Group | 5 | 2015 | 1163 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2015 | 3438 | 0.080 |
Why?
|
| Ovariectomy | 4 | 2013 | 162 | 0.080 |
Why?
|
| Stomatognathic Diseases | 1 | 2010 | 5 | 0.080 |
Why?
|
| Social Behavior | 2 | 2007 | 64 | 0.080 |
Why?
|
| Social Support | 1 | 2011 | 183 | 0.080 |
Why?
|
| Food Preferences | 1 | 2010 | 35 | 0.080 |
Why?
|
| Metals, Heavy | 1 | 2010 | 6 | 0.080 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2010 | 47 | 0.080 |
Why?
|
| Bone Density | 2 | 2010 | 203 | 0.080 |
Why?
|
| Pesticide Residues | 1 | 2009 | 3 | 0.080 |
Why?
|
| Community-Based Participatory Research | 3 | 2017 | 120 | 0.080 |
Why?
|
| Perimenopause | 1 | 2009 | 13 | 0.080 |
Why?
|
| Tobacco, Smokeless | 1 | 2009 | 16 | 0.080 |
Why?
|
| Smoking | 2 | 2011 | 531 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2016 | 876 | 0.070 |
Why?
|
| Anticholesteremic Agents | 1 | 2009 | 38 | 0.070 |
Why?
|
| Probability | 3 | 2017 | 157 | 0.070 |
Why?
|
| Coronary Stenosis | 1 | 2008 | 28 | 0.070 |
Why?
|
| Sex Factors | 4 | 2011 | 675 | 0.070 |
Why?
|
| Carotid Arteries | 1 | 2008 | 101 | 0.070 |
Why?
|
| Age Factors | 3 | 2020 | 1197 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 1307 | 0.070 |
Why?
|
| Adiponectin | 1 | 2008 | 103 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2020 | 28 | 0.070 |
Why?
|
| Herbicides | 1 | 2007 | 3 | 0.070 |
Why?
|
| Sample Size | 1 | 2007 | 39 | 0.070 |
Why?
|
| Diet, Atherogenic | 3 | 2013 | 61 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2009 | 412 | 0.070 |
Why?
|
| Health Surveys | 3 | 2012 | 200 | 0.070 |
Why?
|
| Globulins | 1 | 2007 | 3 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2017 | 3701 | 0.070 |
Why?
|
| Prognosis | 3 | 2020 | 1544 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 360 | 0.070 |
Why?
|
| Progestins | 1 | 2007 | 22 | 0.060 |
Why?
|
| Vulnerable Populations | 2 | 2017 | 40 | 0.060 |
Why?
|
| Physicians, Family | 1 | 2006 | 16 | 0.060 |
Why?
|
| Acetylcholinesterase | 2 | 2017 | 18 | 0.060 |
Why?
|
| Growth Hormone | 1 | 2006 | 15 | 0.060 |
Why?
|
| Vegetables | 1 | 2006 | 39 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 1066 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 55 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2006 | 86 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2006 | 83 | 0.060 |
Why?
|
| Health Status Disparities | 3 | 2011 | 134 | 0.060 |
Why?
|
| HIV Infections | 1 | 2010 | 424 | 0.060 |
Why?
|
| Rural Health | 3 | 2010 | 44 | 0.060 |
Why?
|
| Arthritis | 1 | 2005 | 42 | 0.060 |
Why?
|
| Motor Activity | 1 | 2007 | 327 | 0.060 |
Why?
|
| Glucose | 1 | 2006 | 184 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2017 | 1460 | 0.060 |
Why?
|
| Nonprescription Drugs | 2 | 2019 | 23 | 0.060 |
Why?
|
| Educational Status | 2 | 2019 | 183 | 0.060 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 188 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2005 | 186 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2005 | 223 | 0.060 |
Why?
|
| Breast Neoplasms | 2 | 2008 | 754 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 532 | 0.050 |
Why?
|
| Random Allocation | 3 | 2010 | 229 | 0.050 |
Why?
|
| Self Care | 2 | 2019 | 144 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 767 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 175 | 0.050 |
Why?
|
| Body Weight | 3 | 2012 | 301 | 0.050 |
Why?
|
| Air Conditioning | 2 | 2013 | 7 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2017 | 180 | 0.050 |
Why?
|
| Respiratory Function Tests | 2 | 2015 | 100 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2015 | 292 | 0.050 |
Why?
|
| Neural Conduction | 2 | 2013 | 89 | 0.050 |
Why?
|
| Blood Glucose | 3 | 2013 | 494 | 0.050 |
Why?
|
| Time Factors | 2 | 2020 | 2183 | 0.050 |
Why?
|
| Organizational Culture | 2 | 2012 | 25 | 0.050 |
Why?
|
| Disease Progression | 2 | 2015 | 594 | 0.050 |
Why?
|
| Ovary | 2 | 2012 | 58 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2020 | 1282 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2013 | 381 | 0.040 |
Why?
|
| Diet Surveys | 2 | 2011 | 55 | 0.040 |
Why?
|
| Toothache | 2 | 2011 | 7 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2011 | 148 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2012 | 467 | 0.040 |
Why?
|
| Mothers | 1 | 2020 | 91 | 0.040 |
Why?
|
| Plants, Medicinal | 1 | 2019 | 9 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2010 | 185 | 0.040 |
Why?
|
| Phytotherapy | 1 | 2019 | 37 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 2010 | 57 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 363 | 0.040 |
Why?
|
| Income | 1 | 2018 | 67 | 0.040 |
Why?
|
| Memory | 1 | 2020 | 191 | 0.040 |
Why?
|
| Phosphates | 1 | 2018 | 25 | 0.030 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 51 | 0.030 |
Why?
|
| Endometrium | 2 | 2008 | 42 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 21 | 0.030 |
Why?
|
| Receptors, Estrogen | 2 | 2008 | 106 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2007 | 98 | 0.030 |
Why?
|
| Rest | 1 | 2017 | 52 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2017 | 95 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 45 | 0.030 |
Why?
|
| Oxygen | 1 | 2017 | 144 | 0.030 |
Why?
|
| Internal-External Control | 1 | 2016 | 17 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 225 | 0.030 |
Why?
|
| China | 1 | 2015 | 54 | 0.030 |
Why?
|
| Asian Americans | 1 | 2015 | 95 | 0.030 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2015 | 108 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 90 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2008 | 602 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2015 | 92 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 238 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2015 | 162 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 195 | 0.030 |
Why?
|
| Food Industry | 1 | 2013 | 9 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2014 | 199 | 0.030 |
Why?
|
| Humidity | 1 | 2013 | 4 | 0.030 |
Why?
|
| Rotator Cuff | 1 | 2014 | 74 | 0.030 |
Why?
|
| Latin America | 1 | 2013 | 9 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2013 | 78 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2013 | 23 | 0.020 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 35 | 0.020 |
Why?
|
| Emigration and Immigration | 1 | 2013 | 29 | 0.020 |
Why?
|
| Water Microbiology | 1 | 2012 | 6 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2014 | 125 | 0.020 |
Why?
|
| Protective Devices | 1 | 2012 | 12 | 0.020 |
Why?
|
| Enterobacteriaceae | 1 | 2012 | 11 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2012 | 71 | 0.020 |
Why?
|
| Eating | 1 | 2013 | 74 | 0.020 |
Why?
|
| Posture | 1 | 2012 | 56 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 835 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2012 | 83 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2012 | 34 | 0.020 |
Why?
|
| Physical Examination | 1 | 2012 | 89 | 0.020 |
Why?
|
| Exercise Test | 1 | 2013 | 223 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2013 | 525 | 0.020 |
Why?
|
| Tooth Loss | 1 | 2011 | 7 | 0.020 |
Why?
|
| Accidents, Occupational | 1 | 2011 | 14 | 0.020 |
Why?
|
| Pain | 1 | 2014 | 294 | 0.020 |
Why?
|
| Beverages | 1 | 2011 | 19 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 265 | 0.020 |
Why?
|
| Sleep | 1 | 2012 | 89 | 0.020 |
Why?
|
| Respiratory Sounds | 1 | 2011 | 9 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 764 | 0.020 |
Why?
|
| Menstruation Disturbances | 1 | 2010 | 4 | 0.020 |
Why?
|
| Anovulation | 1 | 2010 | 4 | 0.020 |
Why?
|
| Dermatology | 1 | 2013 | 163 | 0.020 |
Why?
|
| Public Policy | 1 | 2011 | 34 | 0.020 |
Why?
|
| Cyclohexenes | 1 | 2010 | 13 | 0.020 |
Why?
|
| Vinyl Compounds | 1 | 2010 | 9 | 0.020 |
Why?
|
| 2,4-Dichlorophenoxyacetic Acid | 1 | 2010 | 3 | 0.020 |
Why?
|
| Benzoates | 1 | 2010 | 4 | 0.020 |
Why?
|
| Pyridones | 1 | 2010 | 9 | 0.020 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2010 | 8 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2010 | 23 | 0.020 |
Why?
|
| Androstenedione | 1 | 2010 | 5 | 0.020 |
Why?
|
| Condoms | 1 | 2010 | 34 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2010 | 47 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2010 | 30 | 0.020 |
Why?
|
| Poverty | 1 | 2011 | 116 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 573 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 48 | 0.020 |
Why?
|
| Testosterone | 1 | 2010 | 48 | 0.020 |
Why?
|
| Body Burden | 1 | 2010 | 7 | 0.020 |
Why?
|
| Systole | 1 | 2010 | 98 | 0.020 |
Why?
|
| Lung | 1 | 2012 | 265 | 0.020 |
Why?
|
| Diastole | 1 | 2010 | 97 | 0.020 |
Why?
|
| Data Collection | 1 | 2010 | 185 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 201 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2010 | 102 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2010 | 125 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 240 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 131 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 138 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 126 | 0.020 |
Why?
|
| Dental Devices, Home Care | 1 | 2009 | 2 | 0.020 |
Why?
|
| Gingival Hemorrhage | 1 | 2009 | 4 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2009 | 49 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2009 | 78 | 0.020 |
Why?
|
| Family Practice | 1 | 2009 | 49 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 3 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 77 | 0.020 |
Why?
|
| Social Dominance | 1 | 2008 | 18 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 48 | 0.020 |
Why?
|
| Social Class | 1 | 2009 | 93 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 64 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2008 | 125 | 0.020 |
Why?
|
| Independent Living | 1 | 2009 | 105 | 0.020 |
Why?
|
| Health Education | 1 | 2009 | 162 | 0.020 |
Why?
|
| Education, Medical | 1 | 2008 | 70 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 388 | 0.020 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2007 | 5 | 0.020 |
Why?
|
| Administration, Intravaginal | 1 | 2007 | 9 | 0.020 |
Why?
|
| Insect Repellents | 1 | 2007 | 2 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 129 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 887 | 0.020 |
Why?
|
| Placebos | 1 | 2007 | 63 | 0.020 |
Why?
|
| Biopsy | 1 | 2008 | 245 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 33 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2007 | 42 | 0.020 |
Why?
|
| Seed Storage Proteins | 1 | 2007 | 2 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2007 | 4 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 166 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 136 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 189 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 881 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2008 | 498 | 0.020 |
Why?
|
| Professional Practice | 1 | 2006 | 24 | 0.020 |
Why?
|
| Peptides | 1 | 2007 | 125 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 110 | 0.020 |
Why?
|
| Community Networks | 1 | 2006 | 27 | 0.020 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 2006 | 6 | 0.020 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 7 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 255 | 0.020 |
Why?
|
| Hypothalamus | 1 | 2006 | 18 | 0.020 |
Why?
|
| Insulin | 1 | 2008 | 367 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2006 | 56 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 2006 | 58 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2006 | 120 | 0.020 |
Why?
|
| Motivation | 1 | 2006 | 110 | 0.010 |
Why?
|
| Gene Expression | 1 | 2007 | 334 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2006 | 126 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 362 | 0.010 |
Why?
|
| Hippocampus | 1 | 2006 | 171 | 0.010 |
Why?
|
| Infant | 1 | 2007 | 1083 | 0.010 |
Why?
|
| Aging | 1 | 2010 | 938 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 524 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 536 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 1606 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 2511 | 0.010 |
Why?
|